Adrenal insufficiency is managed by hormone replacement therapy, which is far from optimal; the ability to generate functional steroidogenic cells would offer a unique opportunity for a curative approach to restoring the complex feedback regulation of the hypothalamic-pituitary-adrenal axis. Here, we generated human induced steroidogenic cells (hiSCs) from fibroblasts, blood-, and urinederived cells through forced expression of steroidogenic factor-1 and activation of the PKA and LHRH pathways. hiSCs had ultrastructural features resembling steroid-secreting cells, expressed steroidogenic enzymes, and secreted steroid hormones in response to stimuli. hiSCs were viable when transplanted into the mouse kidney capsule and intra-adrenal. Importantly, the hypocortisolism of hiSCs derived from patients with adrenal insufficiency due to congenital adrenal hyperplasia was rescued by expressing the wild-type version of the defective disease-causing enzymes. Our study provides an effective tool with many potential applications for studying adrenal pathobiology in a personalized manner and opens venues for the development of precision therapies.
Correspondence
In Brief Ruiz-Babot et al. generate functional human steroidogenic cells (hiSCs), which are responsive to both pharmacological and physiological stimuli. Moreover, the hypocortisolism in hiSCs derived from patients with congenital adrenal hyperplasia is restored to normal through the incorporation of the wild-type version of the defective disease-causing enzymes.
INTRODUCTION
The adrenal cortex is a major steroid-producing organ, secreting glucocorticoids under the control of adrenocorticotropic hormone (ACTH), secreted by the anterior pituitary gland, and mineralocorticoids under the control of the renin-angiotensin system. Glucocorticoids affect carbohydrate metabolism and mediate the mammalian stress response, and mineralocorticoids control blood volume and salt homeostasis. Primary or secondary adrenal insufficiency (AI) results from adrenal failure or impairment of the hypothalamic-pituitary axis, respectively. In both cases, the cortex fails to secrete sufficient amounts of glucocorticoids and adrenal androgens, but in primary AI, the clinical consequences of aldosterone deficiency make this a more lethal condition. The most frequent cause of primary AI is autosomal recessive congenital adrenal hyperplasia (CAH), which results from defects in enzymes involved in steroid biosynthesis (Merke and Bornstein, 2005) . Patients with AI need life-long management with exogenous steroids: this can be challenging, because no drug suitably mimics the diurnal pattern of cortisol, and objective variables measuring the quality of replacement therapy are lacking. Fine-tuning of replacement therapy leaves only a narrow margin for improvement: underreplacement can result in severe impairment of well-being and incipient crisis, whereas even subtle, chronic over-replacement has the potential to contribute to excess morbidity, including obesity, osteoporosis, hypertension, and impaired glucose tolerance. Therefore, better treatment solutions are urgently needed (Bornstein et al., 2016) .
The ability to generate donor-specific and functional adrenocortical-like cells would facilitate: (1) the next generation of cell-based treatments for AI; (2) the modeling of adrenal-specific diseases; and (3) the testing of personalized interventions on cells derived from patients.
Cells with an adrenocortical-like phenotype have never been obtained in a patient-specific manner; moreover, previous attempts have resulted in cells with very limited steroidogenic potential (Crawford et al., 1997) or have used lines of embryonic stem cells (Jadhav and Jameson, 2011; Yazawa et al., 2011) , mesenchymal stem cells (Gondo et al., 2004 (Gondo et al., , 2008 Mazilu and McCabe, 2011a; Tanaka et al., 2007; Wei et al., 2012; Yazawa et al., 2006 Yazawa et al., , 2009 Yazawa et al., , 2010 , and induced pluripotent stem cells (iPSCs) (Sonoyama et al., 2012) . The prerequisite of all these studies was the forced expression of steroidogenic factor-1 (SF1), a master regulator of adrenogonadal development and function encoded by nuclear receptor subfamily 5, group A, member 1 (NR5A1). SF1 is a true effector of cell fate as it initiates a genetic program driving embryonic mesenchymal cells toward a steroidogenic phenotype/lineage (Schimmer and White, 2010) , and SF1 mutations can result in adrenal insufficiency (Achermann et al., 2001) . Other than SF1, additional transcription factors (TFs), such as wilms tumor 1 (WT1), CBP/p300-interacting transactivator 2 (CITED2), pre-B cell leukemia transcription factor 1 (PBX1), and dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX1) have been shown to be key determinants of adrenal cortex development (Yates et al., 2013) . Moreover, multiple pathways have been implicated in the fine-tuned regulation of adrenocortical development, zonation, and self-renewal (Lerario et al., 2017) .
Here, we show an efficient protocol to reprogram, through stable expression of SF1 and activation of the protein kinase A (PKA) pathway and in the presence of luteinizing-hormonereleasing hormone (LHRH), easily accessible sources of cells from humans (blood, skin, and urine), resulting in human induced steroidogenic cells (hiSCs). These hiSCs expressed steroidogenic enzymes and secreted cortisol in a stimulusdependent manner. hiSCs could be efficiently exploited to study donor-specific disease pathobiology and to test interventions, such as restoration of eucortisolism in hiSCs from CAH patients. Moreover, as a first step to assess whether hiSCs can be a viable option for the development of cell-based treatments for AI, we performed pilot in vivo experiments proving the viability of hiSCs after transplantation into the adrenal glands and under the kidney capsule of mice. These experiments pave the way for further testing of hiSCs in suitable rodent models of AI, such as double adrenalectomised rats (Balyura et al., 2015; Ruiz-Babot et al., 2015) .
RESULTS

Establishment of Human Primary Cultures from Different Cell Sources
Primary cultures of human urine-derived stem cells (USCs), lateoutgrowth endothelial progenitor cells (L-EPCs), and fibroblasts were initially established from healthy donors ( Figure S1 ). Because L-EPCs are phenotypically indistinguishable from bone-marrow-derived endothelial cells (BMECs) (Yoder et al., 2012) , the latter were also used in our experiments.
Generation of hiSCs by Direct Lineage Conversion
Lentiviral vectors encoding SF1 and other TFs (PBX1, DAX1, WT1, and CITED2) were used to infect human primary cells. The vectors co-express GFP bicistronically and contain a mammalian resistance cassette, which was used for selection ( Figure S2A ). Cells were transduced according to the schematic in Figure 1A and as reported in the Experimental Procedures. The expression of the steroidogenic acute regulatory protein (STAR) was used as a readout for initial experiments; STAR mediates the transfer of cholesterol from the outer to the inner mitochondrial membrane, where it is cleaved to pregnenolone and is therefore indispensable and rate limiting for the synthesis of steroids. Transduction of SF1, indeed, induced the expression of STAR ( Figure 1B ).
Other TFs are involved in adrenocortical development and self-renewal, chiefly PBX1, DAX1, WT1, and CITED2 (Yates et al., 2013) . RT-PCR analyses showed that PBX1, DAX1, and CITED2, but not SF1, were expressed at the mRNA level in the four cell types before reprogramming, whereas WT1 was expressed in L-EPCs and BMECs ( Figure S2B ). Unlike SF1, forced expression of the other TFs either alone ( Figure 1B ) or in combination did not induce STAR expression and neither did they enhance the effect of SF1 alone ( Figure 1C ). Lentiviral delivery of SF1 did not significantly alter the endogenous expression levels of PBX1, WT1, DAX1, and CITED2; however, it reduced the expression of WT1 in L-EPCs ( Figure S2B ). These data demonstrate that SF1 alone was able to induce STAR expression in human cells. Interestingly, on forced expression of SF1, cells (irrespective of the source) had a lower proliferation rate, as Figure 1 . Conversion of Human Urine-Derived Stem Cells into Steroidogenic Cells (A) Schematic illustrating our strategy for urine collection, processing, and reprogramming. Urine-derived cells (USCs) were cultured in specific media, and type-II colonies amplified and characterized through flow cytometry. Then they were either banked or expanded for experiments. USCs were infected at passage two with either a lentivirus encoding a transcription factor (TF) within an IRES-GFP vector, a combination of TFs, or mock infected (MOI = 200). Cells were treated with 8-br-cAMP (100 mM) unless stated otherwise and kept in culture for at least eight days before analyses. (B) RT-PCR showing STAR expression on forced expression of each TF. The expression of exogenous SF1, PBX1, WT1, DAX1, and CITED2 was assessed by RT-PCR using primers encompassing the coding-and vector-specific regions. Human adrenal cDNA was used as a positive control for endogenous STAR expression and, along with non-template control (NTC), as a negative control for exogenous TF expression. (C) qRT-PCR analyses of STAR expression on forced expression of SF1 with each TF (upper panel) and of SF1 with or without a combination of TFs (lower panel). (D) Western blot analyses of PCNA and GAPDH expression in hiSCs and mock-reprogrammed USCs from four independent donors eight days after reprogramming (top left panels); cell counting (bottom left panels) and representative images (right panels) of hiSCs obtained from USCs and fibroblasts versus mock-reprogrammed cells. Scale bars, 50 mm. assessed by the expression of proliferating cell nuclear antigen (PCNA) and direct cell counting ( Figure 1D ), and became proliferation arrested three to five days after infection. Cells with this seemingly terminal differentiation phenotype have been maintained for at least two months in culture without loss of viability.
Several treatments were then tested to assess which, if any, would consistently induce an incremental change in the expression of STAR. Activators of PKA, such as dibutyryl cyclic AMP (db-cAMP) or 8-bromo-cyclic AMP (8-br-cAMP), were the most potent inducers of STAR expression, whereas angiotensin II (AngII), potassium (K + ), and all-trans retinoic acid (ATRA) had no effect ( Figure 1E ). Based on these results, 8-br-cAMP (100 mM) was selected to be included in the reprogramming protocol on day two after SF1 transduction.
We next evaluated the dose of SF1 delivered after lentiviral infection and its effect on STAR expression: SF1-expressing cells, but not controls, increased STAR levels in a multiplicity of infection (MOI)-dependent manner ( Figure 1F ). Based on these results, an MOI of 200 was used in subsequent experiments.
Morphologically, all cell types similarly underwent a dramatic change of shape 48-72 hr post-transduction, acquiring an irregular stellate morphology with concomitant reduction of the cytoplasmic volume ( Figure 1G ; Figure S2D ; Movie S1). Despite the neuronal-like morphology, absence of mRNA expression of the neuroectoderm marker paired box gene 6 (PAX6) (Zhang et al., 2010) and the dopaminergic neuronal marker tyrosine hydroxylase (TH) (Lewis et al., 1993) ruled out that these cells could be neuronal-like functionally ( Figure S2C ).
Electron microscopy images showed larger mitochondria with a densely packed inner mitochondrial membrane in USCs-hiSCs in comparison with controls ( Figure 1H ). In addition, reprogrammed cells had an increased expression of the mitochondrial import receptor subunit translocase of outer mitochondrial membrane 20 (TOM20) compared with controls, as assessed by western blotting ( Figure S2E ). Finally, qRT-PCR analyses showed that reprogrammed cells also had enhanced expression of mitochondrial ribosomal RNA 12S ( Figure S2F ). Together, these data suggest that reprogrammed cells potentially are endowed with higher metabolic activity typical of steroidogenic cells.
hiSCs Possess Gene Expression Patterns and Functions Specific for Steroidogenic Cells After cholesterol transfer, steroid hormones are produced after a cascade involving steroidogenic enzymes and intermediate metabolites ( Figure 2A ). We next assessed the expression of steroidogenic enzymes by RT-PCR eight days after reprogramming USCs. As shown in Figure 2B , we detected de novo expression or upregulation of all steroidogenic enzymes analyzed in hiSCs in comparison to cells infected with control lentiviruses. We found expression of cytochrome B5 (CYB5) in both control and reprogrammed cells, while we could not detect expression of sulfotransferase 2A1 (SULT2A1), which is in agreement with the absence of DHEA-S secretion (see below). Fibroblasts, L-EPCs, and BMECs showed an identical pattern of steroidogenic enzyme induction ( Figure S3A ). Concomitant expression of SF1, PBX1, WT1, DAX1, and CITED2 (five TFs) enhanced CYP17A1 and HSD3B2 expression, whereas they decreased CYP21A2 expression and did not change CYP11A1 expression. Four TFs without SF1 had a negligible effect on the expression of steroidogenic enzymes ( Figure S3B) . Moreover, the expression of steroidogenic enzymes was enhanced by 8-br-cAMP (Figure S3C) as was the expression of STAR. Reprogrammed cells did not express the testis marker doublesex and mab-3-related transcription factor 1 (DMRT1) and expressed the ovary marker estrogen receptor alpha (ESR1) at very low levels (ESR1 is also expressed in the adrenal gland, although at a lower level compared with the ovaries) ( Figure S3D ). Moreover, luteinizing hormone receptor (LHR) was undetectable in control USCs and was expressed at a very low level in reprogrammed cells compared with the adrenal gland ( Figure S3D ). These data may suggest a preponderance of adrenocortical-like cells versus a gonadal-like phenotype in reprogrammed cells.
Analyses of hiSCs at the protein level (where specific antibodies were available) confirmed de novo expression of STAR, exogenous SF1, steroidogenic enzymes, as well as the absence of SULT2A1, both by western blot ( Figure 2C ) and immunocytochemistry ( Figure 2D ; Figure S3E ). Differentiation of several independent USC colonies from the same donor or from different donors (either healthy or with congenital adrenal disease) showed similar reprogramming efficiencies as assessed by the expression of STAR protein ( Figure S3F ), STAR mRNA expression, as well as expression of steroidogenic enzymes (data not shown).
We next assessed whether urine-derived hiSCs were hormone producing by analyzing cell supernatants of cells eight days after reprogramming using liquid chromatography-tandem mass spectrometry (LC-MS/MS). As shown in Figure 3A , a very significant increase or de novo production of steroid hormones and precursors was observed in the medium in hiSCs versus control cells. Dehydroepiandrosterone sulfate (DHEA-S) was not detected, which is in keeping with the absence of SULT2A1 (Figures 2B and 2C) . hiSCs had a lower and, despite several interventions, irreversible ( Figure S4 ) cortisol:cortisone ratio compared with human serum or medium from adrenocortical carcinoma H295R cells (Vogeser et al., 2001; Xing et al., 2011) .
Overall, these results showed that hiSCs secrete a full repertoire of adrenocortical hormones, irrespective of the cell source, as hiSCs from fibroblasts and L-EPCs had a similar steroid profile (data not shown).
ACTH is the main stimulator of cortisol release in adult adrenal glands through binding to its receptor MC2R, leading to an activation of PKA signaling (Ruggiero and Lalli, 2016) . Gene expression analyses for MC2R and its accessory protein MRAP detected both transcripts in hiSCs; these transcripts were absent in controls ( Figure 3B ). Cortisol was undetectable in primary cultures before reprogramming or in mock-reprogrammed cells and was produced at low levels in untreated hiSCs; however, a significant and comparable increase was detected after stimulation with ACTH or 8-br-cAMP ( Figure 3C ). These results demonstrated the functionality of hiSCs in regards to their responsiveness to external stimuli, both physiological (ACTH) and pharmacological (8-br-cAMP).
Recently, b-catenin activation has been shown to promote a zona glomerulosa phenotype; moreover, the action of b-catenin was counteracted by PKA activation, which instead promoted a zona fasciculata phenotype (Drelon et al., 2016) . To assess whether the activation of b-catenin had any effect on the expression of zonal-specific markers, reprogrammed cells were treated with recombinant WNT4 (alongside recombinant LH). We found no significant changes in the expression of CYP11B1, CYP11B2, and STAR or on cortisol secretion (Figure 3D) . Finally, it has been reported that the LHRH analog [D-Trp6]-LHRH (Balyura et al., 2015) and bombesin (Malendowicz et al., 1995) acutely stimulate adrenal glucocorticoid release. Both LHRH and bombesin, while not affecting STAR mRNA levels ( Figure 3E ), significantly increased cortisol production in hiSCs; however, only LHRH significantly increased the metabolic activity and lifespan of hiSCs in culture ( Figure 3E ).
Therefore, in our final reprogramming protocol to generate hiSCs, schematized in Figure 3F , Figures  4A-4C) . In implanted cells, nuclear SF1 staining and expression of steroidogenic enzymes, such as CYP11A1, were observed in hiSCs, but not in control cells (Figures 4E-4L) . Interestingly, at three weeks post-transplantation, blood vessels could be detected in hiSC, but not control, xenografts ( Figure 4C , quantification in Figure 4D ), suggesting neovascularization.
To assess differentiation in vivo, cells were implanted orthotopically 24 hr post-infection, at a time when steroidogenic enzymes are not expressed at either the mRNA or the protein level (data not shown); 8-br-cAMP and LHRH were also omitted. Histological analyses of adrenal gland explants after one week, showed no signs of fibrosis or inflammation ( Figures 4M and  4N ). To localize transplanted cells in the context of host adrenocortical cells, sections were immunostained with a GFP antibody ( Figures 4O-4Q) ; the steroidogenic potential and in vivo differentiation of hiSCs was further assessed by their expression of CYP17A1, an enzyme that is epigenetically silenced in adult mice (Missaghian et al., 2009) ; we observed CYP17A1 staining in transplanted cells, but not in mouse adrenocortical cells .
hiSCs embedded in alginate and cultured in vitro had the same gene expression profile and hormonal secretion as monolayer hiSCs (not shown); however, histological analyses of explants (after one week and three weeks) showed features of anuclear necrosis in most transplanted cells with evident signs of karyolysis (nuclear fading) and karyorrhexis (nuclear fragmentation) ( Figure S5B ). The same was observed in alginate slabs embedded with control cells (data not shown). These experiments demonstrate the viability of hiSCs in two out of three experimental settings and pave the way for transplantation experiments on a larger scale to assess hiSCs function in murine models of AI, in which a much greater number of reprogrammed cells are needed. However, hiSCs generated from all cell sources were proliferation arrested ( Figure 1D ), and although we have been unable to find factors promoting proliferation concomitantly with the maintenance of a functional steroidogenic phenotype, a cumate-inducible system was successfully developed, allowing us to generate expandable populations of hiSCs .
hiSCs from CAH Patients Show Impaired Steroidogenesis, and Their Hypocortisolism Can Be Reversed through Restoration of Enzymatic Function Currently available immortalized cell lines (mainly obtained from adrenocortical carcinomas) express certain steroidogenic enzymes at low levels, produce an incomplete steroid profile, and have genetic backgrounds specific for the donors they were derived from. Although animal models of CAH have been generated (Bornstein et al., 1999; Mullins et al., 2009 ), it has not been possible to design disease models involving human steroidogenic cells. For this reason, we evaluated the steroid profile of hiSCs obtained from patients with CAH (Table 1) . CAH due to 21-hydroxylase deficiency (21-OH) is a common autosomal recessive disorder caused by defects in the CYP21A2 gene. Patient #1 harbored one of the most common mutations (p.I172N), resulting in a simple virilizing form of CAH and a residual activity of the enzyme of 1%-10% (Hsu et al., 1996) . LC-MS/MS steroid analyses of parallel differentiations of two independent USCs colonies obtained from patient #1 showed an accumulation of metabolites upstream of the 21-OH enzyme, including 17 hydroxyprogesterone, 17 hydroxypregnenolone, and adrenal androgens and a reduction of those downstream, including DOC and cortisol, as compared with healthy donor controls (Figure 5A) . Lentiviral delivery of wild-type CYP21A2 significantly increased cortisol levels in a dose-dependent manner concomitantly to a reduction of 17-hydroxyprogesterone, 17-hydroxypregnenolone, and testosterone (patient #1 in Figure 5B ). Furthermore, rescue of cortisol hypo-secretion was successfully achieved in hiSCs established from other CAH patients with diverse genetic mutations (Table 1; Figure 5C ). These results demonstrated that hiSCs derived from patients' urine are also excellent experimental models for monogenic congenital adrenal disorders and are amenable to personalized interventions for treatment.
DISCUSSION
Donor-and disease-specific steroidogenic cells as surrogates for disease modeling have been lacking up to now. More significantly, their use could be exploited for the development of cellbased treatment modalities for AI.
We have shown that the use of a single cell fate regulator (SF1/NR5A1), in conjunction with PKA and LHRH signaling, can stably reprogram human adult skin-, blood-, and urinederived cells into hiSCs. Forced expression of other key TFs involved in adrenogonadal differentiation, alone or in combination, was not sufficient to induce hiSCs, nor did their expression with SF1 enhance reprogramming. However, given that there is endogenous expression of DAX1, PBX1, CITED2, and WT1 in non-reprogrammed cells, it is entirely possible that they participate in hiSC induction along with SF1, although the higher dosages delivered by our constructs did not improve reprogramming. Activation of the WNT pathway through WNT4 is associated with zona glomerulosa differentiation, which is prevented by PKA activation (Drelon et al., 2016) . Treatment of hiSCs with recombinant WNT4 did not result in changes of zonalspecific markers nor cortisol secretion; it is possible that, in our experimental setting, forced-expression of SF1 bypasses key differentiation events occurring physiologically at the capsule/ subcapsular region during the normal self-renewal/zonal specification of the gland.
Fibroblasts are the preferred cell substrate for reprogramming, but more recently, alternative cell types have also been used; USCs are highly expandable, have self-renewal capacity, paracrine properties, and multi-differentiation potential (Bharadwaj et al., 2013; Guan et al., 2014) and have been used as substrates for iPSC generation (Zhou et al., 2012) . USC isolation is easy and efficient; we were able to establish cultures with 75% efficacy for one sample and 95% for a second sample, compared with 30% efficacy for L-EPCs (100% for fibroblasts). USCs, L-EPCs, and fibroblasts are all mesoderm derived, however, only USCs are thought to originate from the intermediate mesoderm, a precursor of the adrenocortical and nephritic primordium, which make them an ideal substrate to generate mesodermal tissues, such as adrenogonadal-like cells (Mazilu and McCabe, 2011b) . Given the importance of SF1 dosage during adrenal versus gonadal specification (Bland et al., 2004; Val et al., 2007) , further development of inducible and tunable systems to modulate the expression of SF1 would likely facilitate a more specific adrenocortical or gonadal induction during reprogramming. Gene expression analyses of adrenocortical and gonadal markers already suggested that our protocol might favor a more adrenocortical phenotype ( Figure S3D ).
The functionality of hiSCs makes them an unmatched tool to obtain surrogate adrenocortical cells for in vitro disease modeling. With this in mind, we have derived hiSCs from patients with CAH, showing an altered steroid profile. Importantly, the decrease in cortisol production in hiSCs derived from CAH patients was rescued on expression of the exogenous native forms, irrespective of the defective steroidogenic enzyme. USCs-hiSCs were shown to be viable in vivo when transplanted into mouse adrenal gland tissue and successfully differentiate toward an adrenal-like lineage within the adrenal tissue itself, as cells were implanted 24 hr post-infection when steroidogenic enzymes are not expressed. Whether the surrounding adrenal tissue favors differentiation remains to be explored, as well as the long-term viability/functionality and fate of transplanted cells. hiSCs implanted under the mouse kidney capsule maintained the expression of steroidogenic enzymes and showed well-vascularized tissue at the site of transplantation after three weeks, suggesting viability of those cells in vivo. Remarkably, vascularization was not observed in control implants; this can be explained either by the intrinsic ability of SF1 to regulate adrenocortical vascular remodeling through the expression of angiopoietin-2 (Ferrazde-Souza et al., 2011) or by the very significant upregulation of the potent pro-angiogenic tetraspartin CD9 in hiSCs detected in a proteomic array in all cell sources ( Figure S6 ). CD9, also expressed in the normal adrenal, but with unknown function (Nakamura et al., 2001) , exerts its angiogenic action via exosomes, where it is abundantly expressed (Andreu and Yá ñ ez-Mó , 2014).
Sodium alginate has been used as a 3D scaffold for cell immobilization/delivery in tissue engineering (Bidarra et al., 2014) and might confer some immunoprotection (Llacua et al., 2016) . However, hiSC viability was compromised on implantation; control cells were also negatively affected, suggesting cell-specific toxicity of alginate after grafting in our system (both hiSCs and control cells embedded in alginate were viable and functional in vitro).
Overall, these pilot transplantation experiments showed that viability of hiSCs is affected by the transplantation protocol used. Longer-term experiments with a yet-to-be determined amount of cells would allow for careful assessment of: (1) the number of cells needed to be able to detect cortisol (undetectable in our pilot experiments); (2) the time needed to become fully functional; (3) their viability long term; and (4) their rescuing potential in animal models of AI.
Novel approaches to treating AI are needed for a condition in which mortality rates continue to be 2-fold higher than the background population despite steroid replacement (Bergthorsdottir et al., 2006) . Although newer steroid formulations (e.g., Plenadren and Chronocort) are being developed to mimic circadian rhythms more precisely, replacement remains inherently limited in its responsiveness to physiological need. This study paves the way for the development of alternative approaches to treat AI. For example, hiSCs could be implanted intra-adrenally or encapsulated using immunoisolating chambers, possibly after gene-editing in case of mono/oligogenic disorders, as previously used in beta-cell transplantation (Desai and Shea, 2017) . To this end, USCs have recently been successfully gene edited in a model of human muscle disease (Kim et al., 2016) . This will allow a curative cell replacement therapy for patients with AI.
EXPERIMENTAL PROCEDURES
Further details and an outline of resources used in this work can be found in Supplemental Experimental Procedures.
Materials
All antibodies, plasmids, and primers used are listed in Supplemental Experimental Procedures.
Cell Culture Primary cultures of USCs, fibroblasts, and L-EPCs were isolated as previously described (Martin-Ramirez et al., 2012; Poliandri et al., 2017; Zhou et al., 2012) . BMECs were a kind gift of Dr. Egle Solito Solito et al., 2000) , and HEK293T lines were obtained from ATCC. SF1-inducible cell lines were generated using a SparQ cumate switch pCDH-CuO-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible lentivector (Cambridge Bioscience, Ltd.) expressing SF1. The detailed protocols for the isolation of all cell types are provided in Supplemental Experimental Procedures.
Lentiviral Production and Cell Reprogramming
Lentiviral particles were obtained as previously described (Cribbs et al., 2013) with minor modifications. 60,000 cells per well of a six-well plate were infected with lentiviral particles at a MOI of 200 with 8 mg/mL of polybrene (Millipore, TR-1003-G). The medium was replaced after 12 hr, and treatments with different molecules were started after two days. Cells were cultured for an additional 5-10 days before analysis. Drug concentrations are detailed in Supplemental Experimental Procedures.
Gene Expression Analysis See Supplemental Experimental Procedures for details.
Immunoassays Immunoblotting, immunocytochemistry, and immunohistochemistry were performed as described previously (Guasti et al., 2011; Rodríguez-Asiain et al., 2011) . See Supplemental Experimental Procedures for details.
Hormone Quantification
Hormone quantification was performed using an ELISA Kit (Abcam, ab154996) according to the manufacturer's instructions and LC-MS/MS (Taylor et al., 2017) . See Supplemental Experimental Procedures for details.
Mitochondrial Morphology Studies
Electron microscopy was performed by the Nanovision Centre, Queen Mary University of London, using standardized procedures. (C) Comparison of cortisol levels of hiSCs derived from patients (#2-#5) with several forms of CAH with or without restoration of the wild-type form of the corresponding steroidogenic enzymes. RT-PCR analyses using primers encompassing coding-and vector-specific regions confirmed the expression of the exogenous enzymes (lower panels). See also Table 1 . Data are represented as mean ± SEM, n R 3.
Animal Experiments
All animal experiments were performed in strict accordance with protocols approved by the ethical board of Landesdirektion Sachsen, Germany (protocol no. DD24-5131/354/28). Female 8-week-old C57BL/6 mice were obtained from Charles River Laboratory. Two million cells were transplanted under the kidney capsule and 5 3 10 5 cells concentrated in a total volume of 10 mL were pipetted directly into the adrenal gland. See Supplemental Experimental Procedures for details.
Collection of Urine Samples from Donors
This study has been performed under the ethical approval of the National Health Service, Research Ethic Committee (NHS REC; reference: 13/LO/ 0224). All patients involved were previously informed, and consent forms were obtained before analysis of samples.
Protein Array of Human Reprogrammed Steroidogenic Cells
Protein array was performed by Sciomics, GmbH (Germany) using control and eight-day reprogrammed hiSCs. See Supplemental Experimental Procedures for details.
Data Analysis
Figures and tables were generated using Microsoft Excel, ImageJ, and Adobe Photoshop.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 7, and statistical significance was determined using one-way ANOVA followed by Dunnet's multiple comparison test correction. A Student's t test was performed when only two means were compared. Significance: not significant (ns) p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
The accession number for the protein array data reported in this article is Men- Figure S1 (related to Figure 1 Adipogenic ( The low cortisol/cortisone ratio observed in hiSCs could be due to an enhanced expression of the enzyme hydroxysteroid 11-β dehydrogenase 2 (HSD11B2), responsible for the conversion of cortisol to cortisone, or a downregulation of hydroxysteroid 11-β dehydrogenase 1 (HSD11B1), which catalyzes the reverse reaction in hiSCs compared to controls. A) Immunocytochemistry of HSD11B1 and HSD11B2 in control and SF1-infected cells 8 days post-infection. Scale bars = 20 µm. B) HSD11B1 and HSD11B2 gene (upper panels) and protein (lower panel) expression in in control and SF1-infected cells 8 days post-infection. Human adrenal cDNA and lysate were used as positive controls for RT-PCR and western blot, respectively. Overall, data from A and B showed a strong upregulation of HSD11B2 and a downregulation of HSD11B1 at the mRNA and protein levels. C) Schematic of strategies tested to revert the low cortisol/cortisone ratio in reprogrammed cells: i) forced-expression of HSD11B1, ii) forced-expression of Estrogen-related receptor alpha (ERRα), a TF known to increase CYP11B1 levels 5 ; iii) inhibition of HSD11B2 with liquorice, a compound extracted from the root of the plant Glycyrrhiza glabra 6 . Moreover, co-cultures of hiSCs with fibroblasts and differentiated chromaffin cells were established, as data support the idea that chromaffin cells increase basal steroidogenic activity when co-cultured with adrenocortical cells 7 . D) RT-qPCR analyses of STAR, CYP11B1 and CYP11B2 expression levels, as well as cortisol measurements in urine-derived hiSCs overexpressing various combinations of SF1, HSD11B1 and ERRα or treated with liquorice for 8 days. E) mCherry-expressing PC12 cells were differentiated with nerve growth factor (NGF) and co-cultured with blue fluorescent protein-expressing human fibroblasts and GFP-expressing hiSCs (1: (Welm et al., 2008) . pHIV-EGFP-ERRα (NM_004451.4) was subcloned from pCMV flag ERRα. HSD11B1-FLAG was a gift from Moses Chao (Addgene plasmid # 24096) (Jeanneteau et al., 2008) . pLV-Azurite and pLV-mCherry were a gift from Pantelis Tsoulfas (Addgene plasmid # 36086 and #36084, respectively). Cloning details are shown below: pKMyc was a gift from Ian Macara (Addgene plasmid # 19400) (Joberty et al., 2000) pAd/CMV/DAX1-IRES-nEGFP was a gift from Edward McCabe (Addgene plasmid # 29752) pENTR4-V5-2 (w234-1) was a gift from Eric Campeau (Addgene plasmid # 17426) (Campeau et al., 2009) SB52 was a gift from Shoumo Bhattacharya (Addgene plasmid # 21487) (Bhattacharya et al., 1999) pCMV flag ERR alpha was a gift from Toren Finkel (Addgene plasmid # 10975) (Ichida et al., 2002) Primers: PCR and qPCR primers (Sigma Aldrich) 
Cell culture
Urine-derived stem cells (USCs)
Urine was collected in sterile containers and processed as soon as possible under a sterile tissue culture cabinet. Time from urine collection to processing varied from 1 min to 30 mins. Urine was transferred into sterile 50-ml tubes and centrifuged at 400g for 10 min at room temperature and the supernatant was aspirated. Pellets were gently resuspended and washed with Phosphate Buffered Saline (PBS, Sigma) supplemented with 100 U ml − 1 of penicillin (Sigma), 100 µg ml − 1 of streptomycin (P/S) (Sigma) and 500 ng ml amphotericin B (Sigma) and then 1 ml was transferred into each well of a 12-well plate. 1 ml of primary medium was added to the culture daily for the next 3 days and then medium was changed to proliferation medium (REBM medium (Lonza, CC-3191) supplemented with 10% (vol/vol) FBS, 1% P/S and the REGM SingleQuot kit supplements. Cells were cultured in a designated humidified 37 o C incubator with 5% CO 2 . Appearance of colonies was checked daily from day 4. Type-II colonies were passaged into T75 flasks and then processed for storage in liquid nitrogen or further amplified for CDclassification through flow cytometry or experiments.
Fibroblasts
Fibroblast isolation was performed as described previously (Poliandri et al., 2017) . Briefly, a 4 mm punch biopsy from arm was obtained with a biopsy punch (Stiefel, SmithKline Beecham Ltd, Slough, UK) placed immediately into 15 ml-falcon containing isolation medium (DMEM supplemented with 10% (vol/vol) FBS and 1% P/S). Skin sample was transferred in a 10-dish with digestion media (DMEM/high glucose, 20%FBS (vol/vol), 0.25% collagenase type-I, 0.05% DNAse-I and 1% P/S -all from Sigma-), chopped into 1 square mm cubes and placed at 37 o C tissue culture incubator overnight in a 15 ml-falcon tube with digestion media. Samples were centrifuged and pellet resuspended in 5 ml of isolation medium before plating in gelatin coated T25 flasks. Cells were kept in human fibroblast media (DMEM/High glucose with sodium pyruvate and L-glutamine, 20% FBS (vol/vol) and 1% P/S).
Late outgrowth endothelial progenitor cells (L-EPCs)
L-EPCs were isolated as described previously (Martin-Ramirez et al., 2012) . Briefly, 25-50 ml of blood were diluted 1:1 in PBS in a 50 ml tube. 10 ml of diluted blood was placed on top of 4 ml of Ficoll (GE Healthcare) in 15 ml falcon tubes and centrifuged at 1000 g for 20 min without brake. The buffy coat formed was collected, washed with PBS and centrifuged at 540 g for 7 min with brake. Supernatant was discarded and pellet resuspended in 5 ml of culture medium (EGM-2 Bullekit, Lonza, CC-3162).
Bone marrow endothelial cells (BMEC)
BMEC were a kind gift of Dr Egle Solito Solito et al., 2000) , Queen Mary University, London.
HEK293T
HEK293T were cultured with DMEM, 10% FBS and 1% P/S.
Lentiviral production
Lentiviral particles were prepared using 90% confluent HEK293T cells. 1 hour before transfection medium was replaced to serum-free DMEM. Cells were transfected with pHIV-EGFP vector (with the ORF of interest) together with the packaging vectors pCMVdR8.2 and pMD2.G using polyethileneamine reagent (PEI, Warrington, USA). 2 hours after transfection medium was replaced to DMEM, 10%FBS (vol/vol), 1% P/S. Medium was collect after 24 and 48 hours, filtered and ultracentrifuged at 50.000 g for 1 hour at 16 o C. The resulting pellet was resupended in PBS, aliquoted
and immediately stored at -80 o C.
Precision LentiORF SF1 (NR5A1) lentiviral particles were purchased from Dharmacon (vector pLOC-SF1). The vector encoding SF1 is driven by the CMV promoter. pLOC vector also contains a nuclear localized TurboGFP™ (Evrogen™, Moscow, Russia) and a blasticidin S resistance for selection.
Cell reprogramming
60.000 cells/well of a 6-well plate were infected with lentiviral particles at a MOI=200 with 8µg/ml of polybrene (Millipore, TR-1003-G). Medium was replaced after 12 hours and treatments with different molecules were added after 2 days. Cells were cultured for additional 5 to 10 days prior to analysis. 
Gene expression analysis
RNA was extracted from human adrenals (adjacent to Conn's) and RNA from ovary and testis was purchased from Amsbio (CR560139) and Takara (636533), respectively.
Messenger RNA was purified with RNeasy Mini Kit (Qiagen, 74106) using the RNase-Free DNase Set min at 70 o C to generate cDNA. All products were purchased from NEB. Samples were diluted to a final concentration of 2 ng/ml and 2 ng of cDNA were used for qPCR experiments.
Standard PCR experiments were performed using Taq DNA polymerase (NEB, M0273) and SYBR FAST Universal Kit (KAPA Biosystems, KK4602) for qPCR experiments.
qRT-PCR was performed on a Stratagene Mx3000P thermocycler using KAPA SYBR fast Universal Kit (KAPA Biosystems, KK4602) with 500 nM forward and reverse primers. Data were analyzed using MxPro software (Stratagene, Stockport, UK). Relative quantification analysis was performed following the 2 -ΔΔCT method (Livak and Schmittgen, 2001 ) and data was normalized to Actin expression.
Immunocytochemistry
Control USCs or USCs differentiated for 8 days were fixed using 4% paraformaldehyde in PBS for 20 min on ice. Permeabilization was performed using PBS containing 0.02% saponin for 7 min and 10 mM glycine containing 0.01% saponin for 15 min. Cells were blocked for 1 h with PBS containing 0.01% saponin, 10 mM glycine and 5% (w/v) BSA before incubation with primary antibody (dilution 
Immunohistochemistry
Specimens from in vivo transplantation experiments were either embedded in paraffin or in Optimal
Cutting Temperature (OCT) compound. minutes on ice, blocked with 10% normal goat serum (Sigma-Aldrich, G9023) in PBS-0.1% Triton for 1 hour and incubated overnight with anti-GFP antibody diluted in PBS at room temperature. Slides were washed and then incubated with secondary antibody and DAPI (1:1000) in PBS-Triton and mounted with glass cover slips using PBS:Glycerol (Sigma-Aldrich, G5516) solution at a ratio of 1:3.
Slides were visualized using a Leica DM5500B automated upright microscope and stored at 4 o C.
Chromogenic Immunohistochemistry with DAB on paraffin sections: Sections were deparaffinised in
Xylene incubations, washed in 100% Ethanol and reacted with 3% H2O2 (Sigma Aldrich, 21, diluted in Methanol (Fischer Scientific, M/4000/PC17) for 30 minutes at room temperature to block endogenous peroxidase activity. Sections were rehydrated in decreasing concentrations of Ethanol (100%, 90%, 70% and 50%) for 10 minutes each, followed by incubation in water for 10 minutes and washes in PBS-0.1% Triton. After blocking and overnight incubation with primary antibody as above, slides were incubated with biotinylated secondary antibody for 2 hours at room temperature followed by 1 hour incubation with Avidin-Biotin Complex (ABC) (Vector labs, PK-6100). Slides were developed with DAB (Vector labs, SK-4105) and the reaction was stopped by placing slides in water.
Slides were dehydrated in increasing concentrations of ethanol (50%, 70%, 90% and 100%), xylene and mounted using Vectamount mounting medium (Vector labs, H-5000). Slides were visualized using a Leica DM5500B automated upright microscope equipped with a DFX365 FX camera. 
Western Blot
Immunoblot analysis was performed as described previously (Rodríguez-Asiain et al., 2011) . Briefly, SDS-PAGE was used to size-separate proteins followed by transfer to nitrocellulose membranes (Whatman, UK). After blocking membranes with PBS containing 0,1% Tween-20 and 5% skimmed milk, primary antibody was added over-night. Proteins were detected using secondary fluorescent antibodies (LICOR) and visualized using LICOR Odyssey Scanner 2.2.
Hormone quantification
USCs cell supernatant was collected 8 days after reprogramming. Quantification of metabolites was achieved by mass spectrometry. Cortisol was also measured using cortisol ELISA Kit (Abcam, ab154996) according to the manufacturer's instructions.
Calibrator, Internal Quality Control and Internal Standard solutions:
Individual stock solutions for all analytes and internal standards (Is) were prepared in methanol (each 1000 mg/L). These were then used to prepare combined working solutions containing all analytes for calibration and internal quality control (IQC) purposes. To make these, appropriate volumes of each stock solution were added to a glass tube and then dried down under nitrogen at 60°C. The steroids were then reconstituted in methanol to create calibrator and IQC working solutions each containing: DHEAS (2000 µg/mL), cortisol (200 µg/mL), 17-hydroxypregnenolone (160 µg/mL) 17-hydroxyprogesterone (120 µg/mL), androstenedione (80 µg/mL), pregnenolone, corticosterone, 11-deoxycortisol, 21-deoxycortisol, cortisone (each at 40 µg/mL), testosterone (8 µg/mL) and 11-deoxycorticosterone (4 µg/mL). The working solutions were each further diluted in methanol to create three further working solutions as follows: 3+20 (v/v), 1+39 (v/v) and 1:199 (v/v) . All four working solutions were then used to make appropriate volumes of calibration standard/IQC solution by dilution in DMEM. After thorough mixing and equilibration (24 h, 2-8 °C), calibrators and IQC solutions were portioned (250 µL) in 1.5 mL microcentrifuge tubes (Eppendorf, Stevenage, UK) and stored at -20 °C until required. A combined IS sub-stock solution was prepared in methanol containing deuterated steroids at the following concentrations: DHEAS-D2 (25000 µg/mL), cortisol-D4 (2500 µg/mL), 17-hydroxypregnenolone-D3
(2000 µg/mL) 17-hydroxyprogesterone-D8 (1500 µg/mL), androstenedione-D7 (1000 µg/mL), pregenenolone-D4, corticosterone-D8, 11-deoxycortisol-D2, 21-deoxycortisol-D8, cortisone-D2 (each at 500 µg/mL), testosterone-D3 (100 µg/mL) and 11-deoxycorticosterone-D8 (50 µg/mL). The IS working solution was freshly prepared before each batch by dilution of 50 µL of the IS sub-stock stock solution in acetonitrile to 20 mL in a volumetric flask.
Specimen processing: Portions of frozen calibrators, IQC solutions and unknown media samples were thawed and mixed at room temperature by inversion before analysis. Aliquots (250 µL) of unknown media samples were then transferred into 1.5 mL micro-centrifuge tubes. Subsequently, 250 µL of IS working solution and 500 µL of ice-cold acetonitrile was added to each sample. Tubes were capped and thoroughly vortex-mixed for 30 seconds. Precipitated protein was then pelleted by centrifugation (12,000 rpm, 10 min) and the remaining supernatant transferred to a 10 mL glass tube containing 300 µL of deionised water (dH2O). Ethyl acetate (1 mL) was added and the tube contents vortex-mixed (5 min). Following a brief centrifugation (1,000 rpm, 1 min) to clarify aqueous and organic layers, the top organic layer was removed to a clean tube using a glass pipette. The extract was then evaporated to dryness under nitrogen at 60°C, re-constituted in 200 µL of a 65+35 (v/v) mixture of dH 2 O:methanol and transferred to a glass insert autosampler vial. acquisition were performed using Xcalibur (version 2.2 SP1.48, ThermoFisher Scientific). Postanalysis processing was carried out using LC QuanTM (version 2.6, ThermoFisher Scientific). For assay calibration, peak area ratios (analyte quantifier to IS) were used to construct calibration graphs, with lines fitted by linear regression. The intercepts were not forced through zero, and line weighting was applied (1/concentration). Deuterated ISs were used for all steroids in the developed method.
LC-MS/MS
Flow cytometry
5x10 5 USCs at passage 2 were harvested and resuspended in 100 µl of PBS containing 1,5% BSA, 5%
FBS and 0,5% Na-Azide and were incubated for 30 min on ice with the following antibodies purchased from R&D biosystems:
Antibody
Specie Dilution Code
Anti-CD29 Samples were analyzed in LSR Fortessa Flow Cytometer (BD Biosciences).
Differentiation of USCs into mesenchymal lineages and analysis.
USCs at passage 2 were grown in proliferation medium until confluent. 48 hours later medium was changed to adipogenic (DMEM 10% FBS, 10 ng/ml insulin, 500 mM 3-isobutyl-1-methylxanthine, 1 mM dexamethasone, 1 mM Rosiglitazone), chondrogenic (DMEM 10% FBS, 0.1 mM dexamethasone, 10 ng/ml transforming growth factor (Tgf) β1 (R&D Systems), insulin-transferrin-selenium (ITS) (Life Technologies), and 50 mg/ml ascorbate) and osteogenic (DMEM 10% FBS, 0.1 mM dexamethasone, 100 mg/ml ascorbate , 10 mM β-glycerophosphate) media for 21 days, while controls were kept in proliferation media. Medium was changed twice a week. Cells were stained with Oil Red O (adipogenic lineage), Alcian Blue (chondrogenic linage) and Alizarin Red (osteogenic medium) as reported previously (Guasti et al., 2012) . Images were taken using Zeiss Axio Vert.A1 inverted microscope equipped with an Axiocam 105 camera.
Telomerase activity assay 2x10 4 L-EPCs, fibroblasts and USCs at passage 2 from different donors were harvested and assayed using a Telo TAAGG ELISA kit (Roche, 11854666910) according to the manufacturer's instructions.
HEK293T cells were used as a positive control of the assay.
Animal experiments
Ethics Statement: All animal experiments were performed in strict accordance with animal protocol, approved by the ethical board of Landesdirektion Sachsen, Germany (protocol N: DD24-5131/354/28).
Mice:
Female 8 weeks old C57BL/6 (http://www.criver.com/files/pdfs/ rms/c57bl6/rm_rm_d_c57bl6n_mouse.aspx) and SCID (http://www.criver.com/productsservices/basic-research/find-a-model/fox-chase-scid-mouse) mice were obtained from Charles River
Laboratory. Mice were maintained under 12:12 h light/dark cycle and fed ad libitum. After the arrival the mice were given 3-5 day acclimatization period before beginning of the experiments.
Mice were anesthetized by ketamine/xylazine (100mg/kg Ketamine und 10 mg/kg xylazine).
For cell transplantation under the kidney capsule of SCID mice a longitudinal incision was made with fine scissors in the abdominal skin. A 3-mm incision was made in the kidney capsule, which was carefully separated from the kidney cortex, and cells in alginate or fibrin clot were inserted into the formed pouch. The same procedure with repeated with the second kidney.
Cell encapsulation in alginate: Cells were mixed with 25 µl of 3 % UP-MVG alginate (Novamatrix), dissolved in Custodiol-HTK solution (H.S. Pharma) and polymerized in 70 mM SrCl2 for 15 min. The thickness of the alginate/cell slab was 550 µm. Just before the transplantation, each slab was cut in halves. One half was transplanted under each kidney capsule of C57BL/6 mice.
Cell transplantation in fibrin clot. Thrombin and Fibrinogen were obtained in Sigma-Aldrich. Cells were mixed with 10 µl of Thrombin (10 u/ml). 10 µl of Fibrinogen (10 mg/ml) was added to the cell/Thrombin mixture and immediately placed in the pouch under kidney capsule of SCID mice.
Intraadrenal transplantation. A short longitudinal incision was made on the left lateral body wall to open the retroperitoneal space. The left adrenal was exposed, and 5*10 5 cells concentrated in a total volume of 10 µL were pipetted directly into the adrenal through a capillary tip.
Animals were monitored for up to 3 weeks. Then they were euthanized by cervical dislocation, kidneys or adrenals were removed and collected for immunohistochemical analysis.
Collection of urine samples from donors
This study has been performed under the ethical approval NHS REC form reference: 13/LO/0224. All patients involved were previously informed and consent forms were obtained prior to analysis of samples. For patient #2 clinical and biochemical diagnosis of congenital adrenal hyperplasia due to a presumptive 3B hydroxysteroid dehydrogenase mutation was made on the basis of: a raised serum DHEAS; failure of a clinical response to ovarian suppression for hirsutism and urine gas chromatography demonstrating raised excretion rates of 3 beta-hydroxy-5-ene steroids i.e.
dehydroepiandrosterone and low cortisol metabolite output -tetrahydrocortiosone (THE) and tetrahydrocortisol (THF).
Sequencing
PCR products were purified using QIAquick PCR Purification Kit (Qiagen) and Sanger sequencing was performed by GATC Biotech (Germany). Sequences were analyzed using Chromas 2.6.2 software.
Cell counting assay.
Cell Counting Kit-8 (Sigma) was used to determine the viability of cells in culture according to the manufacturer's instructions.
Establishment of inducible cell lines
SparQ cumate switch pCDH-CuO-MCS-IRES-GFP-EF1-CymR-T2A-Puro All-in-one inducible lentivector (QM812B-1) was purchased from Cambridge Bioscience Ltd, SF1 was subcloned using primers FW ctagctagcaacATGGACTATTCGTACGAC (NheI) and RW gcatcgttcgaaTCAAGTCTGCTTGGCTTG (BstBI) and lentiviral particles were generated as described previously. USCs P2 were infected with lentiviral particles (MOI 50) and stable cell lines were established after two weeks in REBM medium containing 1 mg/ml puromycin. Different concentrations of cumate solution 1000x (QM100A-1, Cambridge Bioscience Ltd) were added to the medium before analysis.
Protein array of human reprogrammed steroidogenic cells
Protein array was performed by Sciomics GmbH (Germany). USCs, fibroblasts and BMEC at P2 were reprogrammed to steroid-producing cells for 8 days.
Protein extraction. Samples were extracted with scioExtract buffer (Sciomics) using the extraction SOPs and the bulk protein concentration was determined by BCA assay.
